SynCore Biotechnology Co Ltd (4192) - Total Liabilities

Latest as of September 2025: NT$14.88 Million TWD ≈ $468.77K USD

Based on the latest financial reports, SynCore Biotechnology Co Ltd (4192) has total liabilities worth NT$14.88 Million TWD (≈ $468.77K USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

SynCore Biotechnology Co Ltd - Total Liabilities Trend (2015–2024)

This chart illustrates how SynCore Biotechnology Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See SynCore Biotechnology Co Ltd (4192) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

SynCore Biotechnology Co Ltd Competitors by Total Liabilities

The table below lists competitors of SynCore Biotechnology Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Seach Medical Group Ltd TA:SEMG	Israel	ILA41.42 Million
Oversea Enterprise Bhd KLSE:0153	Malaysia	RM118.76 Million
Xu Yuan Packaging Technology Co Ltd TWO:8421	Taiwan	NT$1.15 Billion
Plaza Wires Limited NSE:PLAZACABLE	India	Rs531.44 Million
Nagarjuna Fertilizers and Chemicals Limited NSE:NAGAFERT	India	Rs13.32 Billion
Allied Gaming & Entertainment Inc. NASDAQ:AGAE	USA	$52.13 Billion
Porn Prom Metal Public Company Limited BK:PPM	Thailand	฿947.43 Million
JV SPAC Acquisition Corp. Class A Ordinary Share NASDAQ:JVSA	USA	$2.33 Million

Liability Composition Analysis (2015–2024)

This chart breaks down SynCore Biotechnology Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is SynCore Biotechnology Co Ltd worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	15.34	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.06	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.05	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how SynCore Biotechnology Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for SynCore Biotechnology Co Ltd (2015–2024)

The table below shows the annual total liabilities of SynCore Biotechnology Co Ltd from 2015 to 2024.

Year	Total Liabilities	Change
2024-12-31	NT$23.11 Million ≈ $728.19K	+8.89%
2023-12-31	NT$21.23 Million ≈ $668.74K	-88.69%
2022-12-31	NT$187.64 Million ≈ $5.91 Million	-50.82%
2021-12-31	NT$381.52 Million ≈ $12.02 Million	+7.95%
2020-12-31	NT$353.41 Million ≈ $11.13 Million	+132.75%
2019-12-31	NT$151.84 Million ≈ $4.78 Million	+54.77%
2018-12-31	NT$98.11 Million ≈ $3.09 Million	-21.68%
2017-12-31	NT$125.28 Million ≈ $3.95 Million	-15.61%
2016-12-31	NT$148.46 Million ≈ $4.68 Million	-19.52%
2015-12-31	NT$184.46 Million ≈ $5.81 Million	--

About SynCore Biotechnology Co Ltd

TWO:4192 Taiwan Biotechnology

Market Cap

$22.77 Million

NT$722.64 Million TWD

Market Cap Rank

#24722 Global

#1549 in Taiwan

Share Price

NT$20.55

Change (1 day)

+0.24%

52-Week Range

NT$19.50 - NT$28.75

All Time High

NT$537.12